Navigation Links
German High Court Rules in Favor of AmniSure® as New European Guidelines Published
Date:3/4/2011

KARLSRUHE, Germany, March 4, 2011 /PRNewswire/ -- The High Court of Germany (Bundesgerichtshof) handed down a final ruling in favor of AmniSure® International, LLC in its dispute with the Finnish company Medix Biochemica. The court upheld the German Patent Court's ruling that the patent associated with Medix's ActimPROM test is null and void due to its lack of an inventive step. Medix is expected to pay AmniSure® an undisclosed amount to be determined by the courts.

"We are extremely pleased with the decision of the German High Court," said Dr. Michael Friedman, President and CEO of AmniSure® International. "The Court's decision coincided with the publication of the new peer-reviewed Guidelines of the European Association of Perinatal Medicine, which hailed the AmniSure® test as the 'most useful tool' and the 'most accurate bedside test' for diagnosing ruptured fetal membranes(1). The Court's decision closes a chapter for us by bringing a seven-year-long litigation, initiated by Medix, to its rightful conclusion. The publication of the European Guidelines, meanwhile, opens a new chapter for us by establishing the AmniSure® test as the new benchmark for diagnosing ruptured fetal membranes."

(1) The Journal of Maternal-Fetal and Neonatal Medicine, March 2011. ISSN 1476-7058

About AmniSure® International, LLCAmniSure® International, LLC (http://www.amnisure.com) is a medical device company that operates internationally with headquarters in Boston, MA. AmniSure® International pioneered a rapid diagnostic device, AmniSure® ROM Test, which solves a long-standing problem in obstetrics and is rapidly becoming a new global standard in maternal fetal medicine. Contact:info@amnisure.com  617-234-4441 Tel.This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>

SOURCE AmniSure International, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally
2. Mindray Medical to Exhibit at MEDICA 2010 in Dusseldorf, Germany from November 17- 20, 2010
3. Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line
4. Diplomat Specialty Pharmacy Launches Diplomat University - Hires Jennifer Hagerman, PharmD, Pharmacy Professor
5. Roche and German Cancer Research Center (DKFZ) Enter Research Agreement to Predict Cervical Cancer
6. Ziehm Imaging Provides Germanys Federal Armed Forces (Bundeswehr) With Mobile X-Ray Systems
7. WATCHMAN® Receives German Reimbursement Coverage
8. ZS Associates Appoints Pharmaceutical Industry Veteran to Serve the Firms Growing Client Base in Germany
9. Otix Global, Inc. to Discontinue German Operations
10. German District Court Finds RENASYS™ GO NPWT System Non-infringing
11. Dune Medical Devices Announces Positive Interim Results From EU MarginProbe™ Study Presented at German Breast Cancer Society Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
Breaking Medicine Technology:
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
Breaking Medicine News(10 mins):